SCHEMBL29929033

SCHEMBL29929033

CCOC(=O)C1=C[C@@H]2C=C[C@H]1CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 1/20 0.38
MAOA P21397 1/20 0.38
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 4/20 0.35
ABL1 P00519 1/20 0.35
HTT P42858 1/20 0.35
RIN1 Q13671 1/20 0.35
ATM Q13315 1/20 0.35
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA7 P43166 3/20 0.35
CA9 Q16790 3/20 0.35
CA14 Q9ULX7 3/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18053344 1.00 LMNA (0.38) LMNACYP1A2CYP3A4MAOATSHR
SCHEMBL1831584 0.85 TSHR (0.38) LMNACYP1A2CYP3A4MAOATSHR
SCHEMBL11796042 0.77 TSHR (0.45) LMNACYP1A2CYP3A4MAOATSHR
SCHEMBL11525930 0.73 ALDH1A1 (0.41) LMNACYP3A4TSHRRAB9AALDH1A1
SCHEMBL14193666 0.71 CA12 (0.42) LMNACYP3A4TSHRRAB9AALDH1A1
SCHEMBL15820189 0.71 CYP1A2 (0.35) CYP1A2TSHRRAB9AALDH1A1HSD17B10
SCHEMBL15820195 0.70 MEN1 (0.37) TSHRRAB9AALDH1A1HSD17B10MAPT
SCHEMBL8911607 0.70 ALDH1A1 (0.36) CYP1A2CYP3A4TSHRRAB9AALDH1A1
SCHEMBL11582658 0.70 LMNA (0.46) LMNACYP1A2CYP3A4MAOATSHR
SCHEMBL11529682 0.69 ALDH1A1 (0.47) LMNACYP3A4TSHRRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110637022-B Pyrrolopyrimidine derivatives as inhibitors of influenza virus replication 共晶制药公司 2022-09-16 CN disclosed